Home Cart Sign in  
Chemical Structure| 2227149-22-4 Chemical Structure| 2227149-22-4

Structure of DS18561882
CAS No.: 2227149-22-4

Chemical Structure| 2227149-22-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DS18561882 is a highly efficient and selective methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) inhibitor with an IC50 value of 0.0063 μM. It inhibits MTHFD1 with an IC50 value of 0.57 μM and has favorable oral pharmacokinetic properties.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DS18561882

CAS No. :2227149-22-4
Formula : C28H31F3N4O6S
M.W : 608.63
SMILES Code : CS(=O)(NC1=CC=C(C(N2CCC(C3=CC=C(N4C[C@H](C)N(C)CC4)C(C)=C3O5)=C(C5=O)C2)=O)C=C1OC(F)(F)F)=O
MDL No. :MFCD32263053

Safety of DS18561882

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
C4-2B cells 50μM DS18561882 significantly inhibits CRPC cell proliferation J Exp Clin Cancer Res. 2022 Apr 5;41(1):125
LNCaP cells 50μM DS18561882 significantly inhibits CRPC cell proliferation J Exp Clin Cancer Res. 2022 Apr 5;41(1):125
HCC78 20 µM 48 hours Inhibition of MTHFD2 significantly reduced the viability of HCC78 cells. Metabolites. 2022 Jul 15;12(7):652
H1993 20 µM 48 hours Inhibition of MTHFD2 significantly reduced the viability of H1993 cells. Metabolites. 2022 Jul 15;12(7):652
H23 20 µM 48 hours Inhibition of MTHFD2 significantly reduced the viability of H23 cells. Metabolites. 2022 Jul 15;12(7):652
HCC44 20 µM 48 hours Inhibition of MTHFD2 significantly reduced the viability of HCC44 cells. Metabolites. 2022 Jul 15;12(7):652

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Subcutaneous xenograft model Oral 100mg/kg Once daily DS18561882 significantly inhibits CRPC tumor growth J Exp Clin Cancer Res. 2022 Apr 5;41(1):125

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.64mL

0.33mL

0.16mL

8.22mL

1.64mL

0.82mL

16.43mL

3.29mL

1.64mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories